Most recently, Konat Zorzi et, al. has carried out a proof-of-concept experiment [30], in which nanoparticles are used to deliver MUC5AC expression plasmid into ocular surface epithelial cells to treat dry eye syndrome. The gene discussed is MUC5AC; the disease is dry eye syndrome.